13 D Management LLC Innoviva, Inc. Transaction History

13 D Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$9.33 - $12.48 $3.21 Million - $4.29 Million	-343,524 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.33 - $14.49 $53,581 - $75,159	5,187 Added 1.53%	343,524 $3.59 Million
Q2 2020 Aug 14, 2020	SELL	$11.49 - $15.26 $164,950 - $219,072	-14,356 Reduced 4.07%	338,337 $4.73 Million
Q1 2020 May 15, 2020	BUY	$8.11 - $15.23 $173,764 - $326,317	21,426 Added 6.47%	352,693 $4.15 Million
Q4 2019 Feb 13, 2020	SELL	$10.28 - $14.38 $630,379 - $881,795	-61,321 Reduced 15.62%	331,267 $4.69 Million
Q3 2019 Nov 14, 2019	BUY	$10.05 - $14.55 $179,884 - $260,430	17,899 Added 4.78%	392,588 $4.14 Million
Q2 2019 Aug 14, 2019	SELL	$13.1 - $14.95 $3.12 Million - $3.56 Million	-238,231 Reduced 38.87%	374,689 $5.46 Million
Q1 2019 May 02, 2019	BUY	$13.69 - $20.06 $8.39 Million - $12.3 Million	612,920 New	612,920 $8.56 Million

222

78.9M

20K

5.4K

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.39B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of 13 D Management LLC, based on Form 13F filings with the SEC.

Stay updated on 13 D Management LLC with notifications on news.